Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients.

Benoist GE, van Oort IM, Burger DM, Mehra N, van Erp NP.

Cancer Chemother Pharmacol. 2020 Feb 19. doi: 10.1007/s00280-020-04039-7. [Epub ahead of print]

PMID:
32076807
2.

Left sinus of Valsalva-Electroanatomic basis and outcomes with ablation for outflow tract arrhythmias.

Kapa S, Mehra N, Deshmukh AJ, Friedman PA, Asirvatham SJ.

J Cardiovasc Electrophysiol. 2020 Feb 11. doi: 10.1111/jce.14388. [Epub ahead of print]

PMID:
32048387
3.

Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands.

Kuppen MCP, Westgeest HM, van den Eertwegh AJM, Coenen JLLM, van Moorselaar RJA, van den Berg P, Geenen MM, Mehra N, Hendriks MP, Lampe MI, van de Luijtgaarden ACM, Peters FPJ, Roeleveld TA, Smilde TJ, de Wit R, van Oort IM, Gerritsen WR, Uyl-de Groot CA.

Clin Genitourin Cancer. 2019 Dec 5. pii: S1558-7673(19)30366-0. doi: 10.1016/j.clgc.2019.11.015. [Epub ahead of print]

PMID:
31883940
4.

Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases.

Suri R, Neupane YR, Mehra N, Jain GK, Kohli K.

Med Hypotheses. 2020 Mar;136:109518. doi: 10.1016/j.mehy.2019.109518. Epub 2019 Dec 6.

PMID:
31837522
5.

Characteristics of the complete mitochondrial genome of the monotypic genus Arctictis (Family: Viverridae) and its phylogenetic implications.

Mitra S, Kunteepuram V, Koepfli KP, Mehra N, Tabasum W, Sreenivas A, Gaur A.

PeerJ. 2019 Nov 25;7:e8033. doi: 10.7717/peerj.8033. eCollection 2019.

6.

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.

van Dessel LF, van Riet J, Smits M, Zhu Y, Hamberg P, van der Heijden MS, Bergman AM, van Oort IM, de Wit R, Voest EE, Steeghs N, Yamaguchi TN, Livingstone J, Boutros PC, Martens JWM, Sleijfer S, Cuppen E, Zwart W, van de Werken HJG, Mehra N, Lolkema MP.

Nat Commun. 2019 Nov 20;10(1):5251. doi: 10.1038/s41467-019-13084-7.

7.

Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic Leukemia.

Reddy P, Shankar R, Koshy T, Radhakrishnan V, Ganesan P, Jayachandran PK, Dhanushkodi M, Mehra N, Krupashankar S, Manasa P, Nagare RP, Swaminathan R, Kannan K, Sagar TG, Ganesan TS.

Indian J Hematol Blood Transfus. 2019 Oct;35(4):640-648. doi: 10.1007/s12288-019-01123-8. Epub 2019 Apr 17.

PMID:
31741615
8.

Osmotic Dilator Intra-Abdominal Perforation: A Case Report.

Harjee R, Bahrani R, Chan M, Mehra N, Pang E, Fitzsimmons B.

J Obstet Gynaecol Can. 2019 Nov 11. pii: S1701-2163(19)30684-X. doi: 10.1016/j.jogc.2019.07.006. [Epub ahead of print]

PMID:
31727589
9.

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.

Westdorp H, Creemers JHA, van Oort IM, Schreibelt G, Gorris MAJ, Mehra N, Simons M, de Goede AL, van Rossum MM, Croockewit AJ, Figdor CG, Witjes JA, Aarntzen EHJG, Mus RDM, Brüning M, Petry K, Gotthardt M, Barentsz JO, de Vries IJM, Gerritsen WR.

J Immunother Cancer. 2019 Nov 14;7(1):302. doi: 10.1186/s40425-019-0787-6.

10.

Expecting failure yet obtaining success.

Mehra N, Asirvatham SJ.

J Cardiovasc Electrophysiol. 2019 Dec;30(12):2995-2997. doi: 10.1111/jce.14225. Epub 2019 Oct 22. No abstract available.

PMID:
31642149
11.

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry.

Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Coenen JLLM, van den Bergh ACMF, Mehra N, Somford DM, Bergman AM, Ten Bokkel Huinink D, Fossion L, Geenen MM, Hendriks MP, van de Luijtgaarden ACM, Polee MB, Weijl NI, van de Wouw AJ, de Wit R, Uyl-de Groot CA, Gerritsen WR.

Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30146-4. doi: 10.1016/j.euo.2019.09.005. [Epub ahead of print]

PMID:
31601523
12.

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.

van der Velden DL, Hoes LR, van der Wijngaart H, van Berge Henegouwen JM, van Werkhoven E, Roepman P, Schilsky RL, de Leng WWJ, Huitema ADR, Nuijen B, Nederlof PM, van Herpen CML, de Groot DJA, Devriese LA, Hoeben A, de Jonge MJA, Chalabi M, Smit EF, de Langen AJ, Mehra N, Labots M, Kapiteijn E, Sleijfer S, Cuppen E, Verheul HMW, Gelderblom H, Voest EE.

Nature. 2019 Oct;574(7776):127-131. doi: 10.1038/s41586-019-1600-x. Epub 2019 Sep 30.

PMID:
31570881
13.

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.

Lubberman FJE, Benoist GE, Gerritsen W, Burger DM, Mehra N, Hamberg P, van Oort I, van Erp NP.

Cancer Chemother Pharmacol. 2019 Dec;84(6):1179-1185. doi: 10.1007/s00280-019-03952-w. Epub 2019 Sep 12.

14.

68Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients.

van Steenbergen TRF, Smits M, Scheenen TWJ, van Oort IM, Nagarajah J, Rovers MM, Mehra N, Fütterer JJ.

Cardiovasc Intervent Radiol. 2020 Jan;43(1):147-154. doi: 10.1007/s00270-019-02312-8. Epub 2019 Aug 23.

15.

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands.

Westgeest HM, Kuppen MCP, van den Eertwegh AJM, de Wit R, Coenen JLLM, van den Berg HPP, Mehra N, van Oort IM, Fossion LMCL, Hendriks MP, Bloemendal HJ, van de Luijtgaarden ACM, Ten Bokkel Huinink D, van den Bergh ACMF, van den Bosch J, Polee MB, Weijl N, Bergman AM, Uyl-de Groot CA, Gerritsen WR.

Clin Genitourin Cancer. 2019 Oct;17(5):e946-e956. doi: 10.1016/j.clgc.2019.05.018. Epub 2019 May 31.

PMID:
31439536
16.

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.

Aluwini SS, Mehra N, Lolkema MP, Oprea-Lager DE, Yakar D, Stoevelaar H, van der Poel H; Dutch Oligometastatic Prostate Cancer Working Group, Busstra M, de Jong IJ, de Reijke T, de Vries K, Heijmink S, Jenster G, Klaver S, Kneppers J, Lavalaye J, Leyten G, Moonen L, Nagaraj J, Noordzij W, Osanto S, Oving I, Schaake E, Scheenen T, Schoots I, Sedelaar M, Somford D, van den Berkmortel F, van der Hulle T, van der Voort van Zyp J, van Leeuwen P, van Moorselaar J, van Oort I, Vogel W, Westgeest H.

Eur Urol Oncol. 2019 Aug 7. pii: S2588-9311(19)30113-0. doi: 10.1016/j.euo.2019.07.010. [Epub ahead of print]

PMID:
31401014
17.

Anatomic Considerations Relevant to Atrial and Ventricular Arrhythmias.

Nan J, Sugrue A, Ladas TP, Mehra N, Asirvatham SJ.

Card Electrophysiol Clin. 2019 Sep;11(3):421-432. doi: 10.1016/j.ccep.2019.04.003. Review.

PMID:
31400867
18.

Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma.

Ganesan P, Mehra N, Joel A, Radhakrishnan V, Dhanushkodi M, Perumal Kalayarasi J, Kannan K, Ganesan TS, Sagar TG.

Leuk Res. 2019 Sep;84:106188. doi: 10.1016/j.leukres.2019.106188. Epub 2019 Jul 11.

PMID:
31325732
19.

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis.

Rescigno P, Dolling D, Conteduca V, Rediti M, Bianchini D, Lolli C, Ong M, Li H, Omlin AG, Schmid S, Caffo O, Zivi A, Pezaro CJ, Morley C, Olmos D, Romero-Laorden N, Castro E, Saez MI, Mehra N, Smeenk S, Sideris S, Gil T, Banks P, Sandhu SK, Sternberg CN, De Giorgi U, De Bono JS.

Eur Urol Oncol. 2019 Jul 12. pii: S2588-9311(19)30083-5. doi: 10.1016/j.euo.2019.06.008. [Epub ahead of print]

20.

Coronary Artery Disease in Adults With Coarctation of Aorta: Incidence, Risk Factors, and Outcomes.

Egbe AC, Rihal CS, Thomas A, Boler A, Mehra N, Andersen K, Kothapalli S, Taggart NW, Connolly HM.

J Am Heart Assoc. 2019 Jun 18;8(12):e012056. doi: 10.1161/JAHA.119.012056. Epub 2019 Jun 14.

21.

Cytokine gene polymorphisms among North Indians: Implications for genetic predisposition?

Singh P, Rajput R, Mehra NK, Vajpayee M, Sarin R.

Infect Genet Evol. 2019 Sep;73:450-459. doi: 10.1016/j.meegid.2019.06.004. Epub 2019 Jun 4.

PMID:
31173933
22.

Right Ventriculocutaneous Fistula Treated With Radiofrequency Ablation.

Mehra NS, Goel K, Asirvatham SJ, Rihal CS.

JACC Cardiovasc Interv. 2019 Sep 9;12(17):1737-1738. doi: 10.1016/j.jcin.2019.04.020. Epub 2019 May 29. No abstract available.

PMID:
31153843
23.

A quality improvement and educational initiative to reduce morbidity associated with massive postpartum hemorrhage.

Smith CC, Tessier F, Hutfield A, Hutcheon JA, Mehra N.

Int J Gynaecol Obstet. 2019 Aug;146(2):257-262. doi: 10.1002/ijgo.12874. Epub 2019 Jun 20.

PMID:
31141161
24.

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.

Sumanasuriya S, Omlin A, Armstrong A, Attard G, Chi KN, Bevan CL, Shibakawa A, IJzerman MJ, De Laere B, Lolkema M, Lorente D, Luo J, Mehra N, Olmos D, Scher H, Soule H, Stoecklein NH, Terstappen LWMM, Waugh D, de Bono JS.

Eur Urol Oncol. 2018 Jun;1(2):151-159. doi: 10.1016/j.euo.2018.02.009. Epub 2018 May 15. Review.

25.

Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre.

Kalaiyarasi JP, Ganesan P, Kannan K, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Krupashankar S, Mehra N, Sagar TG.

Indian J Hematol Blood Transfus. 2019 Apr;35(2):248-254. doi: 10.1007/s12288-018-1023-0. Epub 2018 Oct 1.

PMID:
30988559
26.

First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands.

van Kalmthout L, Braat A, Lam M, van Leeuwaarde R, Krijger G, Ververs T, Mehra N, Bins A, Hunting J, de Keizer B.

Clin Nucl Med. 2019 Jun;44(6):446-451. doi: 10.1097/RLU.0000000000002561.

PMID:
30985436
27.

Comparative evaluation of effects of natural antioxidants on the shear bond strength of composite resin to bleached enamel.

Rana R, Kaushik M, Sharma R, Reddy P, Mehra N.

Indian J Dent Res. 2019 Jan-Feb;30(1):112-116. doi: 10.4103/ijdr.IJDR_397_17.

28.

Outcomes of Oral Metronomic Therapy in Patients with Lymphomas.

Mailankody S, Ganesan P, Joshi A, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Mehra N, Kalaiyarasi JP, Kannan K, Sagar TG.

Indian J Hematol Blood Transfus. 2019 Jan;35(1):50-56. doi: 10.1007/s12288-018-0995-0. Epub 2018 Aug 2.

29.

Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era.

Ganesan P, Ganesan TS, Radhakrishnan V, Sagar TG, Kannan K, Dhanushkodi M, Kalayarasi JP, Mehra N.

Indian J Hematol Blood Transfus. 2019 Jan;35(1):37-42. doi: 10.1007/s12288-018-1009-y. Epub 2018 Sep 8.

30.

Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.

Ihtisham K, Ramanujam B, Srivastava S, Mehra NK, Kaur G, Khanna N, Jain S, Kumar S, Kaul B, Samudrala R, Tripathi M.

Seizure. 2019 Mar;66:99-103. doi: 10.1016/j.seizure.2019.02.011. Epub 2019 Feb 20.

PMID:
30826555
31.

64-Year-Old Man With Subacute Altered Mental Status and Headache.

Mehra NS, Ward RC, Issa M.

Mayo Clin Proc. 2019 Apr;94(4):709-713. doi: 10.1016/j.mayocp.2018.05.040. Epub 2019 Feb 13. No abstract available.

PMID:
30770097
32.

Tuberculosis Burden among Household Pediatric Contacts of Adult Tuberculosis Patients: Correspondence.

Husaini Doctor T, Mehra N, Vaidya PC.

Indian J Pediatr. 2019 Jul;86(7):667-668. doi: 10.1007/s12098-019-02874-y. Epub 2019 Feb 11. No abstract available.

PMID:
30741385
33.

Diverse human leukocyte antigen association of type 1 diabetes in north India.

Kumar N, Mehra NK, Kanga U, Kaur G, Tandon N, Chuzho N, Mishra G, Neolia SC.

J Diabetes. 2019 Sep;11(9):719-728. doi: 10.1111/1753-0407.12898. Epub 2019 Feb 7.

PMID:
30614662
34.

Role of QRS Fragmentation for Risk Stratification in Adults With Tetralogy of Fallot.

Egbe AC, Miranda WR, Mehra N, Ammash NM, Missula VR, Madhavan M, Deshmukh AJ, Farouk Abdelsamid M, Kothapalli S, Connolly HM.

J Am Heart Assoc. 2018 Dec 18;7(24):e010274. doi: 10.1161/JAHA.118.010274.

35.

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives.

van der Doelen MJ, Mehra N, Hermsen R, Janssen MJR, Gerritsen WR, van Oort IM.

Clin Genitourin Cancer. 2019 Apr;17(2):79-87. doi: 10.1016/j.clgc.2018.11.008. Epub 2018 Nov 22. Review.

PMID:
30558834
36.

HLA-A*02 repertoires in three defined population groups from North and Central India: Punjabi Khatries, Kashmiri Brahmins and Sahariya Tribe.

Saxena A, Sharma G, Tyagi S, Mourya M, Coshic P, Tiwari PK, Mehra NK, Kanga U.

HLA. 2019 Jan;93(1):16-23. doi: 10.1111/tan.13447. Epub 2018 Dec 27.

PMID:
30516033
37.

Effect of different periodontal ligament simulating materials on the incidence of dentinal cracks during root canal preparation.

Rathi A, Chowdhry P, Kaushik M, Reddy P, Roshni, Mehra N.

J Dent Res Dent Clin Dent Prospects. 2018 Summer;12(3):196-200. doi: 10.15171/joddd.2018.030. Epub 2018 Sep 18.

38.

A fascinating story of the discovery & development of biologicals for use in clinical medicine.

Malaviya AN, Mehra NK.

Indian J Med Res. 2018 Sep;148(3):263-278. doi: 10.4103/ijmr.IJMR_1471_18. Review.

39.

Clinical Management of Root Resorption: A Report of Three Cases.

Mehra N, Yadav M, Kaushik M, Roshni R.

Cureus. 2018 Aug 27;10(8):e3215. doi: 10.7759/cureus.3215.

40.

Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability.

Vaidya B, Shukla SK, Kolluru S, Huen M, Mulla N, Mehra N, Kanabar D, Palakurthi S, Ayehunie S, Muth A, Gupta V.

Carbohydr Polym. 2019 Jan 15;204:68-77. doi: 10.1016/j.carbpol.2018.09.080. Epub 2018 Oct 4.

PMID:
30366544
41.

Stress distribution in endodontically treated abfracted mandibular premolar restored with different cements and crowns: A three-dimensional finite element analysis.

Kaushik M, Kumar U, Sharma R, Mehra N, Rathi A.

J Conserv Dent. 2018 Sep-Oct;21(5):557-561. doi: 10.4103/JCD.JCD_206_18.

42.

The Combination of Enzalutamide and Opioids: A Painful Pitfall?

Benoist GE, van Oort IM, Burger DM, Koch BCP, Mehra N, van Erp NP.

Eur Urol. 2019 Feb;75(2):351-352. doi: 10.1016/j.eururo.2018.09.011. Epub 2018 Sep 21. No abstract available.

PMID:
30245086
43.

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis.

Lambros MB, Seed G, Sumanasuriya S, Gil V, Crespo M, Fontes M, Chandler R, Mehra N, Fowler G, Ebbs B, Flohr P, Miranda S, Yuan W, Mackay A, Ferreira A, Pereira R, Bertan C, Figueiredo I, Riisnaes R, Rodrigues DN, Sharp A, Goodall J, Boysen G, Carreira S, Bianchini D, Rescigno P, Zafeiriou Z, Hunt J, Moloney D, Hamilton L, Neves RP, Swennenhuis J, Andree K, Stoecklein NH, Terstappen LWMM, de Bono JS.

Clin Cancer Res. 2018 Nov 15;24(22):5635-5644. doi: 10.1158/1078-0432.CCR-18-0862. Epub 2018 Aug 9.

44.

Development and Evaluation of Talazoparib Nanoemulsion for Systemic Therapy of BRCA1-mutant Cancer.

Mehra NK, Tekmal RR, Palakurthi S.

Anticancer Res. 2018 Aug;38(8):4493-4503. doi: 10.21873/anticanres.12753.

PMID:
30061215
45.

Permselective H2/CO2 Separation and Desalination of Hybrid GO/rGO Membranes with Controlled Pre-cross-linking.

Lin H, Liu R, Dangwal S, Kim SJ, Mehra N, Li Y, Zhu J.

ACS Appl Mater Interfaces. 2018 Aug 22;10(33):28166-28175. doi: 10.1021/acsami.8b05296. Epub 2018 Aug 7.

PMID:
30036034
46.

Now the dust has settled over immune checkpoint blockade in metastatic prostate cancer.

Mehra N, Gerritsen W.

Ann Oncol. 2018 Aug 1;29(8):1620-1622. doi: 10.1093/annonc/mdy239. No abstract available.

48.

N° 286-Liste de contrôle de la sécurité chirurgicale en obstétrique-gynécologie.

Singh SS, Mehra N, Hopkins L.

J Obstet Gynaecol Can. 2018 Mar;40(3):e243-e249. doi: 10.1016/j.jogc.2018.01.019. No abstract available.

PMID:
29525050
49.

No. 286-Surgical Safety Checklist in Obstetrics and Gynaecology.

Singh SS, Mehra N, Hopkins L.

J Obstet Gynaecol Can. 2018 Mar;40(3):e237-e242. doi: 10.1016/j.jogc.2018.01.018.

PMID:
29525049
50.

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).

Mehra N, Dolling D, Sumanasuriya S, Christova R, Pope L, Carreira S, Seed G, Yuan W, Goodall J, Hall E, Flohr P, Boysen G, Bianchini D, Sartor O, Eisenberger MA, Fizazi K, Oudard S, Chadjaa M, Macé S, de Bono JS.

Eur Urol. 2018 Sep;74(3):283-291. doi: 10.1016/j.eururo.2018.02.013. Epub 2018 Feb 28.

Supplemental Content

Support Center